Clinical Trial Update: Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study of dose-dense MVAC chemotherapy with pegfilgrastim support in patients with muscle-invasive bladder cancer; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Doxorubicin (doxorubicin)
• METHOTREXATE (METHOTREXATE)
• Pegfilgrastim (pegfilgrastim)
• Vinblastine (vinblastine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Bladder Cancer, Muscle-invasive Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-05-15